EUVIMEDEUVIMED entdecken
Crossref

Glimepiride for persistent hyperglycemia in extremely low birth weight infants: A case series

Kazuki Hatayama iD, Yuka Sano Wada iD, Ayano Tanzawa, Tetsuya Isayama, Yushi Ito

Pediatrics International · 2025-01 · 67 (1)

DOI: 10.1111/ped.70110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 05.06.2025. Verfasst von Kazuki Hatayama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, Center for Maternal-Fetal, Neonatal, and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Jap…. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

extremely low birth weight infantsglimepirideneonatal hyperglycemia

Autor:innen und Institutionen

  • Division of Neonatology, Center for Maternal-Fetal, Neonatal, and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.
  • Department of Pharmacy, National Center for Child Health and Development, Tokyo, Japan.

ORCID-Profile: Kazuki Hatayama, Yuka Sano Wada

Zitieren

APA

Hatayama, K., Wada, Y. S., Tanzawa, A., Isayama, T., & Ito, Y. (2025). Glimepiride for persistent hyperglycemia in extremely low birth weight infants: A case series. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70110

Vancouver

Hatayama K, Wada YS, Tanzawa A, Isayama T, Ito Y. Glimepiride for persistent hyperglycemia in extremely low birth weight infants: A case series. Pediatrics International. 2025;67(1). doi:10.1111/ped.70110

BibTeX
@article{Hatayama2025,
  author = {Hatayama, Kazuki and Wada, Yuka Sano and Tanzawa, Ayano and Isayama, Tetsuya and Ito, Yushi},
  title = {Glimepiride for persistent hyperglycemia in extremely low birth weight infants: A case series},
  journal = {Pediatrics International},
  year = {2025},
  volume = {67},
  number = {1},
  doi = {10.1111/ped.70110}
}
Kostenlos starten →